Invention Grant
- Patent Title: Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor
-
Application No.: US12494472Application Date: 2009-06-30
-
Publication No.: US08173781B2Publication Date: 2012-05-08
- Inventor: Eisuke Mekada , Ryo Iwamoto , Shingo Miyamoto , Kenya Shitara , Akiko Furuya , Kazuyasu Nakamura , Kumiko Takahashi , Hiroshi Ando , Kazuhiro Masuda , Yuka Sasaki
- Applicant: Eisuke Mekada , Ryo Iwamoto , Shingo Miyamoto , Kenya Shitara , Akiko Furuya , Kazuyasu Nakamura , Kumiko Takahashi , Hiroshi Ando , Kazuhiro Masuda , Yuka Sasaki
- Applicant Address: JP Tokyo
- Assignee: Kyowa Hakko Kirin Co., Ltd
- Current Assignee: Kyowa Hakko Kirin Co., Ltd
- Current Assignee Address: JP Tokyo
- Agency: Sughrue Mion, PLLC
- Priority: JPP.2006-157279 20060606
- Main IPC: C07K16/00
- IPC: C07K16/00 ; A61K39/395 ; C12P21/08
Abstract:
Medicaments for treating diseases related to HB-EGF escalation are in demand. The present invention provides a monoclonal antibody or an antibody fragment thereof which binds to a cell membrane-bound HB-EGF, a membrane type HB-EGF and a secretory HB-EGF.
Public/Granted literature
- US20110052595A1 MONOCLONAL ANTIBODY CAPABLE OF BINDING TO HEPARIN-BINDING EPIDERMAL GROWTH FACTOR-LIKE GROWTH FACTOR Public/Granted day:2011-03-03
Information query
